Evidence map›Paper›PMID 26884330›Full record

ArticleThe Journal of biological chemistry2016

Manipulation of Interleukin-1β and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence.

Dmitry Ratner, M Pontus A Orning, Kristian K Starheim, Robyn Marty-Roix, Megan K Proulx, Jon D Goguen, Egil Lien

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Raver1 linksProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Journal of bacteriology · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. A TNF-IL-1 circuit controlsbioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Journal of oral microbiology · 2021
    Article
  15. The pyrin inflammasome in host-microbe interactions.Current opinion in microbiology · 2020
    Review
  16. Review
  17. Article
  18. Unraveling neutrophil-F1000Research · 2019
    Review
  19. Human Macrophages Clear the Biovar Microtus Strain ofFrontiers in cellular and infection microbiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Dmitry RatnerFrom the Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
M Pontus A OrningFrom the Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, the Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway, and.
Kristian K StarheimFrom the Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, the Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway, and.
Robyn Marty-RoixFrom the Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Megan K Proulxthe Department of Microbiology and Physiological Systems, University of Massachusetts, Worcester, Massachusetts 01655.
Jon D Goguenthe Department of Microbiology and Physiological Systems, University of Massachusetts, Worcester, Massachusetts 01655.
Egil LienFrom the Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, the Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway, and egil.lien@umassmed.edu.
University of Massachusetts Chan Medical School · USNorwegian University of Science and Technology · NO

Funding

Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
Innate Immunity Training ProgramT32AI095213 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2025
$2.5M
NIAID NIH HHS T32 AI007538NIAID NIH HHS T32 AI095213
6 · The paper itself

Abstract

Innate immunity plays a central role in resolving infections by pathogens. Host survival during plague, caused by the Gram-negative bacterium Yersinia pestis, is favored by a robust early innate immune response initiated by IL-1β and IL-18. These cytokines are produced by a two-step mechanism involving NF-κB-mediated pro-cytokine production and inflammasome-driven maturation into bioactive inflammatory mediators. Because of the anti-microbial effects induced by IL-1β/IL-18, it may be desirable for pathogens to manipulate their production. Y. pestis type III secretion system effectors YopJ and YopM can interfere with different parts of this process. Both effectors have been reported to influence inflammasome caspase-1 activity; YopJ promotes caspase-8-dependent cell death and caspase-1 cleavage, whereas YopM inhibits caspase-1 activity via an incompletely understood mechanism. However, neither effector appears essential for full virulence in vivo Here we report that the sum of influences by YopJ and YopM on IL-1β/IL-18 release is suppressive. In the absence of YopM, YopJ minimally affects caspase-1 cleavage but suppresses IL-1β, IL-18, and other cytokines and chemokines. Importantly, we find that Y. pestis containing combined deletions of YopJ and YopM induces elevated levels of IL-1β/IL-18 in vitro and in vivo and is significantly attenuated in a mouse model of bubonic plague. The reduced virulence of the YopJ-YopM mutant is dependent on the presence of IL-1β, IL-18, and caspase-1. Thus, we conclude that Y. pestis YopJ and YopM can both exert a tight control of host IL-1β/IL-18 production to benefit the bacteria, resulting in a redundant impact on virulence.

Indexed as

AnimalsBacterial Outer Membrane ProteinsBacterial ProteinsCells, CulturedImmunity, InnateInflammasomesInterleukin-18Interleukin-1betaMacrophagesMiceReal-Time Polymerase Chain ReactionVirulenceYersinia InfectionsYersinia pestisBacterial Outer Membrane ProteinsBacterial ProteinsInflammasomesInterleukin-18Interleukin-1betayopM protein, YersiniaYopP protein, Yersiniacaspase 1 (CASP1)cell deathinflammasomeinterleukin-18 (IL-18)interleukin 1 (IL-1)macrophagetype III secretion system (T3SS)Yersinia pestisYopJYopM

Identifiers

PMID26884330
PMCPMC4858993
OpenAlexW2346706608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.